FDA chief wants other rich countries to share drug development costsBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7419.830-d (Published 09 October 2003) Cite this as: BMJ 2003;327:830
- Janice Hopkins Tanne
- New York
Trying to make new drugs “affordable, safe, and innovative” is a “global crisis,” said Mark McClellan, commissioner of the US Food and Drug Administration, in a speech to the first international colloquium on generic medicine in Cancun, Mexico. He said the United States was paying too high a price for developing new drugs and called for other rich countries to share development costs, perhaps in proportion to their national income.
Developing a new drug costs more than $800m (£480m; €690m), Dr McClellan said. As countries tighten their price regulations, drug companies …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial